PortfoliosLab logo
FBIOX vs. IBB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FBIOX and IBB is 0.65, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

FBIOX vs. IBB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Biotechnology Portfolio (FBIOX) and iShares Nasdaq Biotechnology ETF (IBB). The values are adjusted to include any dividend payments, if applicable.

200.00%300.00%400.00%500.00%600.00%NovemberDecember2025FebruaryMarchApril
453.19%
280.54%
FBIOX
IBB

Key characteristics

Sharpe Ratio

FBIOX:

0.03

IBB:

-0.17

Sortino Ratio

FBIOX:

0.19

IBB:

-0.09

Omega Ratio

FBIOX:

1.02

IBB:

0.99

Calmar Ratio

FBIOX:

0.02

IBB:

-0.10

Martin Ratio

FBIOX:

0.06

IBB:

-0.44

Ulcer Index

FBIOX:

10.06%

IBB:

7.85%

Daily Std Dev

FBIOX:

22.77%

IBB:

21.07%

Max Drawdown

FBIOX:

-71.96%

IBB:

-62.85%

Current Drawdown

FBIOX:

-25.50%

IBB:

-29.32%

Returns By Period

In the year-to-date period, FBIOX achieves a -5.87% return, which is significantly higher than IBB's -6.72% return. Over the past 10 years, FBIOX has outperformed IBB with an annualized return of 3.41%, while IBB has yielded a comparatively lower 1.27% annualized return.


FBIOX

YTD

-5.87%

1M

-5.87%

6M

-16.12%

1Y

2.70%

5Y*

2.58%

10Y*

3.41%

IBB

YTD

-6.72%

1M

-5.43%

6M

-12.81%

1Y

-2.32%

5Y*

0.02%

10Y*

1.27%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FBIOX vs. IBB - Expense Ratio Comparison

FBIOX has a 0.69% expense ratio, which is higher than IBB's 0.47% expense ratio.


Expense ratio chart for FBIOX: current value is 0.69%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
FBIOX: 0.69%
Expense ratio chart for IBB: current value is 0.47%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
IBB: 0.47%

Risk-Adjusted Performance

FBIOX vs. IBB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBIOX
The Risk-Adjusted Performance Rank of FBIOX is 2525
Overall Rank
The Sharpe Ratio Rank of FBIOX is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of FBIOX is 2626
Sortino Ratio Rank
The Omega Ratio Rank of FBIOX is 2525
Omega Ratio Rank
The Calmar Ratio Rank of FBIOX is 2525
Calmar Ratio Rank
The Martin Ratio Rank of FBIOX is 2525
Martin Ratio Rank

IBB
The Risk-Adjusted Performance Rank of IBB is 1414
Overall Rank
The Sharpe Ratio Rank of IBB is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of IBB is 1414
Sortino Ratio Rank
The Omega Ratio Rank of IBB is 1414
Omega Ratio Rank
The Calmar Ratio Rank of IBB is 1414
Calmar Ratio Rank
The Martin Ratio Rank of IBB is 1313
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FBIOX vs. IBB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for FBIOX, currently valued at 0.03, compared to the broader market-1.000.001.002.003.00
FBIOX: 0.03
IBB: -0.17
The chart of Sortino ratio for FBIOX, currently valued at 0.19, compared to the broader market-2.000.002.004.006.008.00
FBIOX: 0.19
IBB: -0.09
The chart of Omega ratio for FBIOX, currently valued at 1.02, compared to the broader market0.501.001.502.002.503.00
FBIOX: 1.02
IBB: 0.99
The chart of Calmar ratio for FBIOX, currently valued at 0.02, compared to the broader market0.002.004.006.008.0010.00
FBIOX: 0.02
IBB: -0.10
The chart of Martin ratio for FBIOX, currently valued at 0.06, compared to the broader market0.0010.0020.0030.0040.0050.00
FBIOX: 0.06
IBB: -0.44

The current FBIOX Sharpe Ratio is 0.03, which is higher than the IBB Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of FBIOX and IBB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.03
-0.17
FBIOX
IBB

Dividends

FBIOX vs. IBB - Dividend Comparison

FBIOX's dividend yield for the trailing twelve months is around 0.93%, more than IBB's 0.31% yield.


TTM20242023202220212020201920182017201620152014
FBIOX
Fidelity Select Biotechnology Portfolio
0.93%1.21%0.45%0.00%14.48%19.46%8.89%11.18%1.41%3.42%6.71%10.77%
IBB
iShares Nasdaq Biotechnology ETF
0.31%0.29%0.26%0.31%0.21%0.20%0.17%0.19%0.30%0.19%0.03%0.15%

Drawdowns

FBIOX vs. IBB - Drawdown Comparison

The maximum FBIOX drawdown since its inception was -71.96%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for FBIOX and IBB. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%NovemberDecember2025FebruaryMarchApril
-25.50%
-29.32%
FBIOX
IBB

Volatility

FBIOX vs. IBB - Volatility Comparison

Fidelity Select Biotechnology Portfolio (FBIOX) and iShares Nasdaq Biotechnology ETF (IBB) have volatilities of 12.15% and 12.76%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%NovemberDecember2025FebruaryMarchApril
12.15%
12.76%
FBIOX
IBB